News

Avella Newsroom

January 1, 1970|
Avella CEO Letter Regarding Direct and Indirect Remuneration (DIR) Fees
March 29, 2017| CATEGORIES: Specialty Pharmacy , Press Release

Calling on Centers for Medicare & Medicaid Services to Curb Below-Cost Reimbursement to Specialty Pharmacies by Pharmaceutical Benefit Managers, to Clarify Medicare Definitions, & Promote Accurate & Responsible Reimbursement

Direct & Indirect Remuneration (DIR) fees erode access to vital clinical services & breakthrough drugs for the most vulnerable Americans, increasing costs across the board & negatively impacting seniors & their caregivers, pharmacies, & taxpayers that fund Medicare

Last week, Frier Levitt, LLC; and the National Association of Specialty Pharmacy (NASP) published a white paper describing the advent and negative consequences of Direct and Indirect Remuneration (DIR) fees. America’s seniors need the Centers for Medicare and Medicaid Services (CMS) to take immediate action to stop Pharmaceutical Benefits Managers (PBMs) from levying inappropriate, unreasonable and unsustainable DIR fees on specialty pharmacies.

NASP Announces Patient Satisfaction Survey
September 9, 2016| CATEGORIES: Corporate , Press Mention
The National Association of Specialty Pharmacy (NASP) has announced a new patient satisfaction survey tool. “NASP wants to establish a gold standard of well-thought-out patient satisfaction measures that specialty pharmacies hold ourselves to," said Todd Speranzo, Vice President, Marketing, Avella Specialty Pharmacy.
Rebecca Shanahan, CEO, Avella Specialty Pharmacy, Discusses NASP Legal Day
August 10, 2016| CATEGORIES: Corporate , Press Mention
Rebecca Shanahan, CEO of Avella Specialty Pharmacy, joins host Suzette DiMascio, CHE, CMCE, CPC, in Expert Interview Series podcast to discuss NASP Legal Day, and what it means for the legal and regulatory aspects of operating a specialty pharmacy.
Dispensing Medications In Shadow of the Storm
July 29, 2016| CATEGORIES: Corporate , Press Mention
Storms, natural disasters, blackouts and other significant disruptions—even something as benign as Pope Francis’ visit to the United States in 2015—can put major roadblocks in the path of specialty pharmacies’ commitments to provide their patients with all their needed medications on a timely basis. The often critical nature of specialty medications, combined with the temperature sensitivity of many of these drugs, means that neither snow, wind, rain, dark of night nor the Northeast blackout of 2003 can be allowed to delay a specialty pharmacy from its appointed dispensing rounds. So how do they prepare?
5 Questions for your VP of Business Development
April 8, 2016| CATEGORIES: Corporate , Partners , Press Mention
Growing by nearly 250 percent over a three-year period, Avella Specialty Pharmacy recently found itself listed on the Inc. 5000. Helping to harness that growth is Leslie Yendro, who here shares five key questions that she—and all business development executives in healthcare—needs to consistently ask and answer to stay ahead. 
Avella and mscripts to present mobile health study findings at the 2015 Armada Specialty Pharmacy Summit
April 14, 2015| CATEGORIES: Corporate , Press Release

Joint presentation will discuss the value of technology-enabled adherence strategies

Executives from Avella Specialty Pharmacy and mscripts, a leading mobile health provider, will present findings from a compelling new study on medication adherence at the 2015 Armada Specialty Pharmacy Summit on Thursday, May 7.

Avella Specialty Pharmacy Unveils its Third Issue of Dispensing Excellence
November 3, 2014| CATEGORIES: Corporate , Press Release

Publication is filled with informative articles on the latest trends, opportunities and challenges related to specialty drugs

Avella Specialty Pharmacy has just released its third issue of Dispensing Excellence, a publication aimed at healthcare providers, nurses, medical assistants and their patients. The 28-page magazine is distributed by Avella in order to share insight on the latest trends and developments in the world of specialty drugs as well as the conditions they help manage. 

Avella Specialty Pharmacy Achieves Accreditation Through ACHC
October 2, 2014| CATEGORIES: Corporate , Press Release

Avella is proud to announce that it has achieved accreditation as a specialty pharmacy through Accreditation Commission for Health Care (ACHC).

Avella among a group of specialty pharmacies now ready to distribute a new medication for adults with active psoriatic arthritis
March 27, 2014| CATEGORIES: Corporate , Press Release

Otezla® (apremilast) is the first oral therapy FDA approved to improve signs and symptoms including physical functioning for patients with this condition.

Just days after the Food and Drug Administration approved Otezla, a new oral therapy to treat active psoriatic arthritis (PsA) in adult patients, Avella has announced that it is prepared to begin distributing the drug. At this time, Avella is one of a select number of pharmacies that are contracted by Celgene, the drug manufacturer, to dispense the product at launch.

Avella Registers as an “Outsourcing Facility” with the FDA
March 18, 2014| CATEGORIES: Corporate , Press Release

New program aims to help providers identify compounding facilities that meet more rigorous standards around quality and patient safety.

Avella Specialty Pharmacy has announced that it has registered with the FDA as an Outsourcing Facility for sterile compounding as outlined in the recently enacted Drug Quality and Security Act (DQSA). Outsource Facilities must consent to greater federal oversight including more frequent inspections and are required to demonstrate their adherence to specific “good manufacturing practices.”

News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Subscribe
News Alerts
If you would like to receive email updates from Avella Specialty Pharmacy, please complete the information below.
Subscribe